Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Delayed ¹⁸F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: results from the CAMONA study.
Blomberg BA, Thomassen A, Takx RA, Hildebrandt MG, Simonsen JA, Buch-Olsen KM, Diederichsen AC, Mickley H, Alavi A, Høilund-Carlsen PF. Blomberg BA, et al. Among authors: hildebrandt mg. J Nucl Cardiol. 2014 Jun;21(3):588-97. doi: 10.1007/s12350-014-9884-6. Epub 2014 Mar 15. J Nucl Cardiol. 2014. PMID: 24633502 Clinical Trial.
[18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.
Hildebrandt MG, Gerke O, Baun C, Falch K, Hansen JA, Farahani ZA, Petersen H, Larsen LB, Duvnjak S, Buskevica I, Bektas S, Søe K, Jylling AM, Ewertz M, Alavi A, Høilund-Carlsen PF. Hildebrandt MG, et al. J Clin Oncol. 2016 Jun 1;34(16):1889-97. doi: 10.1200/JCO.2015.63.5185. Epub 2016 Mar 21. J Clin Oncol. 2016. PMID: 27001573
Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer's disease and mild cognitive impairment.
Segtnan EA, Majdi A, Constantinescu C, Grupe P, Gerke O, Dali HÍ, Strøm OE, Holm J, Alavi A, Sadigh-Eteghad S, Wermuth L, Hildebrandt MG, Gjedde A, Høilund-Carlsen PF. Segtnan EA, et al. Among authors: hildebrandt mg. Eur J Nucl Med Mol Imaging. 2019 May;46(5):1164-1174. doi: 10.1007/s00259-018-4248-0. Epub 2019 Jan 12. Eur J Nucl Med Mol Imaging. 2019. PMID: 30637500
Hybrid PET/MRI in major cancers: a scoping review.
Morsing A, Hildebrandt MG, Vilstrup MH, Wallenius SE, Gerke O, Petersen H, Johansen A, Andersen TL, Høilund-Carlsen PF. Morsing A, et al. Among authors: hildebrandt mg. Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2138-2151. doi: 10.1007/s00259-019-04402-8. Epub 2019 Jul 2. Eur J Nucl Med Mol Imaging. 2019. PMID: 31267161
FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond.
Hildebrandt MG, Lauridsen JF, Vogsen M, Holm J, Vilstrup MH, Braad PE, Gerke O, Thomassen M, Ewertz M, Høilund-Carlsen PF; Centre for Personalized Response Monitoring in Oncology (PREMIO). Hildebrandt MG, et al. Cancers (Basel). 2019 Aug 15;11(8):1190. doi: 10.3390/cancers11081190. Cancers (Basel). 2019. PMID: 31443324 Free PMC article.
54 results